The latest board meeting for Cartesian Therapeutics Inc took place on 08 Aug 2025, for the purpose of Cartesian Therapeutics Inc Second Quarter Earnings Results for 2025See details
Cartesian Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of -89.6%, and profit growth estimate of -5.4% for FY25, based on top 9 analyst calls.